The PPAR-γ antagonist T007 inhibits RANKL-induced osteoclastogenesis and counteracts OVX-induced bone loss in mice

The PPAR-γ antagonist T007 inhibits RANKL-induced osteoclastogenesis and counteracts OVX-induced bone loss in mice

Abstract Background Osteoclasts are key determinant cellular components implicated in the development and progression of disorders driven by bone damage. Herein, we studied the upshot of T007, an antagonist of peroxisome proliferator-activated receptor-gamma (PPARγ), on osteoclastogenesis using cell...

Full description

Bibliographic Details
Main Authors:	Xiang Li, Lei Ning, Jianjun Ma, Ziang Xie, Xiangde Zhao, Gangliang Wang, Xinyu Wan, Pengcheng Qiu, Teng Yao, Haoming Wang, Shunwu Fan, Shuanglin Wan
Format:	Article
Language:	English
Published:	BMC 2019-10-01
Series:	Cell Communication and Signaling
Subjects:	Osteoclasts T007 Peroxisome proliferator-activated receptor-gamma Osteoporosis Receptor activator of nuclear factor-κB ligand
Online Access:	http://link.springer.com/article/10.1186/s12964-019-0442-3

Similar Items

Inhibition of RANKL-Induced Osteoclastogenesis by Novel Mutant RANKL
by: Yuria Jang, et al.
Published: (2021-01-01)

Cistanche deserticola polysaccharide inhibits OVX-induced bone loss in mice and RANKL-induced osteoclastogenesis
by: Wen Xiao, et al.
Published: (2021-06-01)

Inhibiting Monoacylglycerol Lipase Suppresses RANKL-Induced Osteoclastogenesis and Alleviates Ovariectomy-Induced Bone Loss
by: Hui Liu, et al.
Published: (2021-03-01)

Green tea (Camellia sinensis) aqueous extract alleviates postmenopausal osteoporosis in ovariectomized rats and prevents RANKL-induced osteoclastogenesis in vitro
by: Xin Wu, et al.
Published: (2018-10-01)

Asiatic Acid Inhibits OVX-Induced Osteoporosis and Osteoclastogenesis Via Regulating RANKL-Mediated NF-κb and Nfatc1 Signaling Pathways
by: Guoju Hong, et al.
Published: (2020-03-01)

Celastrol Attenuates RANKL-Induced Osteoclastogenesis in vitro and Reduces Titanium Particle-Induced Osteolysis and Ovariectomy-Induced Bone Loss in vivo
by: Qiang Xu, et al.
Published: (2021-06-01)

Sphingosine-1-Phosphate Receptor 2 Controls Podosome Components Induced by RANKL Affecting Osteoclastogenesis and Bone Resorption
by: Li-Chien Hsu, et al.
Published: (2019-01-01)

Gamabufotalin Inhibits Osteoclastgenesis and Counteracts Estrogen-Deficient Bone Loss in Mice by Suppressing RANKL-Induced NF-κB and ERK/MAPK Pathways
by: Kaiqiang Sun, et al.
Published: (2021-04-01)

Betulinic Acid Protects From Bone Loss in Ovariectomized Mice and Suppresses RANKL-Associated Osteoclastogenesis by Inhibiting the MAPK and NFATc1 Pathways
by: Jiyong Wei, et al.
Published: (2020-07-01)

Activation of PPARs Modulates Signalling Pathways and Expression of Regulatory Genes in Osteoclasts Derived from Human CD14+ Monocytes
by: Abe Kasonga, et al.
Published: (2019-04-01)

Oxymatrine Attenuates Osteoclastogenesis via Modulation of ROS-Mediated SREBP2 Signaling and Counteracts Ovariectomy-Induced Osteoporosis
by: Chao Jiang, et al.
Published: (2021-05-01)

Niclosamide and its derivative DK‐520 inhibit RANKL‐induced osteoclastogenesis
by: Yurui Jiao, et al.
Published: (2020-08-01)

Vindoline Inhibits RANKL-Induced Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss in Mice
by: Yunfei Zhan, et al.
Published: (2020-01-01)

Aspirin inhibits RANKL-induced osteoclast differentiation in dendritic cells by suppressing NF-κB and NFATc1 activation
by: Lili Wu, et al.
Published: (2019-12-01)

Possible mechanism of phthalates-induced tumorigenesis
by: Yu-Chih Wang, et al.
Published: (2012-07-01)

Monocrotaline Suppresses RANKL-Induced Osteoclastogenesis In Vitro and Prevents LPS-Induced Bone Loss In Vivo
by: Cheng-Ming Wei, et al.
Published: (2018-07-01)

Extrahepatic PPARα modulates fatty acid oxidation and attenuates fasting-induced hepatosteatosis in mice
by: Chad N. Brocker, et al.
Published: (2018-11-01)

Inhibitory effects of ChondroT and its constituent herbs on RANKL-induced osteoclastogenesis
by: Rui Hong Guo, et al.
Published: (2019-11-01)

Tetrandrine Prevents Bone Loss in Ovariectomized Mice by Inhibiting RANKL-Induced Osteoclastogenesis
by: Zeyuan Zhong, et al.
Published: (2020-01-01)

Egg White Ovotransferrin Attenuates RANKL-Induced Osteoclastogenesis and Bone Resorption
by: Nan Shang, et al.
Published: (2019-09-01)

Lipidomic profiling reveals protective function of fatty acid oxidation in cocaine-induced hepatotoxicity
by: Xiaolei Shi, et al.
Published: (2012-11-01)

Magnesium Lithospermate B Protects against Lipopolysaccharide-Induced Bone Loss by Inhibiting RANKL/RANK Pathway
by: Jihai Wang, et al.
Published: (2018-02-01)

Nrf2 is required for suppressing osteoclast RANKL-induced differentiation in RAW 264.7 cells via inactivating cannabinoid receptor type 2 with AM630
by: Wan Li, et al.
Published: (2020-06-01)

Oleanolic acid inhibits RANKL-induced osteoclastogenesis via ER alpha/miR-503/RANK signaling pathway in RAW264.7 cells
by: Bao-ping Xie, et al.
Published: (2019-09-01)

Effect of berberine on PPARα-NO signalling pathway in vascular smooth muscle cell proliferation induced by angiotensin IV
by: Hongmei Qiu, et al.
Published: (2017-01-01)

Fermented Sea Tangle (<i>Laminaria japonica</i> Aresch) Suppresses RANKL-Induced Osteoclastogenesis by Scavenging ROS in RAW 264.7 Cells
by: Jin-Woo Jeong, et al.
Published: (2019-07-01)

Lipids, Inflammation and Pathology of the Human: Role of Peroxisome Prolifera tor-Activated Receptors (Literature Review)
by: M.S. Rasin
Published: (2013-08-01)

The PPAR-gamma agonist pioglitazone protects cortical neurons from inflammatory mediators via improvement in peroxisomal function
by: Gray Elizabeth, et al.
Published: (2012-04-01)

Kynurenine Promotes RANKL–Induced Osteoclastogenesis In Vitro by Activating the Aryl Hydrocarbon Receptor Pathway
by: Nada H. Eisa, et al.
Published: (2020-10-01)

Shikonin mitigates ovariectomy-induced bone loss and RANKL-induced osteoclastogenesis via TRAF6-mediated signaling pathways
by: Kai Chen, et al.
Published: (2020-06-01)

Retinal homeostasis and metformin-induced protection are not affected by retina-specific Pparδ knockout
by: Lei Xu, et al.
Published: (2020-10-01)

The effects of hydroxysafflor yellow A on PPARγ expression in glutamate⁃induced neuron damage
by: Xing⁃miao LIU, et al.
Published: (2012-06-01)

Sarsasapogenin Suppresses RANKL-Induced Osteoclastogenesis in vitro and Prevents Lipopolysaccharide-Induced Bone Loss in vivo
by: Peng J, et al.
Published: (2020-08-01)

Attenuation of high-fat diet-induced fatty liver through PPARα activation by stevioside
by: Chang-Hao Jia, et al.
Published: (2019-06-01)

Regulation of ABCA1 expression in human keratinocytes and murine epidermis
by: Yan J. Jiang, et al.
Published: (2006-10-01)

Flavopiridol Protects Bone Tissue by Attenuating RANKL Induced Osteoclast Formation
by: Zi’ang Hu, et al.
Published: (2018-05-01)

Complementary Immunometabolic Effects of Exercise and PPARβ/δ Agonist in the Context of Diet-Induced Weight Loss in Obese Female Mice
by: Sébastien Le Garf, et al.
Published: (2019-10-01)

Alliin Attenuated RANKL-Induced Osteoclastogenesis by Scavenging Reactive Oxygen Species through Inhibiting Nox1
by: Yueqi Chen, et al.
Published: (2016-09-01)

Carbon Monoxide Inhibits Receptor Activator of NF-κB (RANKL)-Induced Osteoclastogenesis
by: Feng-Jen Tseng, et al.
Published: (2015-07-01)

Tyloxapol inhibits RANKL-stimulated osteoclastogenesis and ovariectomized-induced bone loss by restraining NF-κB and MAPK activation
by: Wen Guo, et al.
Published: (2021-05-01)